Vetark Calci-Dust 150g - Calcium Supplement For Reptiles

Product Information

You may report side effects to the FDA at 1-800-332-1088. You may also report side effects at https://www.fda.gov/medwatch.

Overdose can lead to hypercalcaemia and hypervitaminosis D. Symptoms of hypercalcaemia may include anorexia, thirst, nausea, vomiting, constipation, abdominal pain, muscle weakness, fatigue, mental disturbances, polidipsia, polyuria, bone pain, nephrocalcinosis, renal calculi and in severe cases, cardiac arrhythmias. Extreme hypercalcaemia may result in coma and death. Persistently high calcium levels may lead to irreversible renal damage and soft tissue calcification. Treatment with orlistat may potentially impair the absorption of fat-soluble vitamins (A, D, E and K). CALCI-D should therefore be taken at least two hours after theadministration of orlistat. b) For the correction of calcium and Vitamin D deficiency in the elderly. Calci-D may be used as an adjunct to specific therapy for osteoporosis, in patients with either established vitamin D and calcium combined deficiencies or in those patients at high risk of needing such therapeutic supplements.If you are pregnant or breast-feeding, think you may be pregnant or areplanning to have a baby, ask yourdoctor or pharmacist for advice beforetaking this medicine.

The MHRA has taken the decision to approve Pharmacy legal status for Calci-D chewable tablets under the following conditions: tetracycline antibiotics: when takingthese leave at least three hours beforetaking CALCI-D . Do not take themat the same time.if you have had kidney stones or otherkidney problems (your doctor willneed to monitor your treatmentcarefully if your kidneys are notworking properly to make sure you donot build up too much calcium in yourblood)

Indirect dangers” are considered to be when treatment might mask an underlying condition that requires medical attention. CALCI-D may be used as an adjunct to specific therapy for osteoporosis, in patients with either established vitamin D and calcium combined deficiencies or in thosepatients at high risk of needing such therapeutic supplements. 4.2 Posology and method of administration There are no data regarding the possible effects of CALCI-D on male and female fertility..(see section 5.3) 4.7 Effects on ability to drive and use machines If you have an allergy to calcium or any other part of Calci-Chew ( calcium carbonate chewable tablets).

More about Calci-Chew (calcium carbonate)

Calcium and Vitamin D have a fundamental effect on “bone rebuilding” processes and it is for this reason that they are used in those conditions of the elderly patientcharacterised by a negative calcium balance with low levels of circulating Vitamin Dand elevated serum levels of parathormone. This secondary hyperparathyroidism iseffectively corrected by the combined effect of calcium carbonate and Vitamin D3,the active ingredients in CALCI-D . Taking too much colecalciferol can cause calcium and phosphate to build up in your body (hypercalcaemia). Consilient Health Limited proposed to make Calci-D chewable tablets available through pharmacies with the following terms of reclassification: Once in the area it’s absolutely worth visiting the renowned Certosa Monumentale and the Museum of Natural History and the University of Pisa Territory. Patients with renal dysfunction: CALCI-D should not be used in patients with severe renal dysfunction. 4.3 Contraindications

CALCI-D can be used during breast-feeding. Calcium and vitamin D3 pass into breast milk. This should be considered when given additional vitamin D to the child. Long-term vitamin D deficiency can cause bone loss, muscle weakness, falls and fractures in older people. Direct danger’ means that a danger may be present if the product causes adverse reactions that are important.Davy H (1808). “Electro-chemical researches on the decomposition of the earths; with observations on the metals obtained from the alkaline earths, and on the amalgam procured from ammonia”. Philosophical Transactions of the Royal Society of London. 98: 333–370. Bibcode: 1808RSPT...98..333D. doi: 10.1098/rstl.1808.0023. CALCI-D chewable tablets may be prescribed by doctors to treat andprevent vitamin D/calcium deficiency. Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinalproduct. Healthcare professionals are asked to report any suspected adverse reactionsvia the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard. 4.9 Overdose